Filing Details
- Accession Number:
- 0001683168-22-005877
- Form Type:
- 13G Filing
- Publication Date:
- 2022-08-16 20:00:00
- Filed By:
- Meteora Capital, Llc
- Company:
- Revelation Biosciences Inc.
- Filing Date:
- 2022-08-17
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Meteora Capital | 0 | 0 | 0 | 0 | 0 | 0% |
| Vik Mittal | 0 | 0 | 0 | 0 | 0 | 0% |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
Revelation Biosciences, Inc.
(Name of Issuer)
Common Stock, par value $0.001 per share
(Title of Class of Securities)
76135L101 **
(CUSIP Number)
February 28, 2022
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
| [ X ] Rule 13d-1(b) | |
| [ ] Rule 13d-1(c) | |
| [ ] Rule 13d-1(d) |
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
** On January 10, 2022, the Issuer announced the Common Stock would trade under a new CUSIP 76135L101 as of January 11, 2022. The Issuer’s CUSIP as of December 31, 2021 was 716421102.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 76135L101
| Page 2 of 6 Pages | ||||
| 1 | NAMES OF REPORTING PERSONS:
| ||||
| Meteora Capital, LLC | |||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):
| ||||
| (a) [ ] | |||||
| (b) [ ] | |||||
| 3 | SEC USE ONLY: | ||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION:
| ||||
| Delaware | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER:
0 | |||
| 6 | SHARED VOTING POWER:
0 | ||||
| 7 | SOLE DISPOSITIVE POWER:
0 | ||||
| 8 | SHARED DISPOSITIVE POWER:
0 | ||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
| ||||
| 0 | |||||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
| ||||
| [ ] | |||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
| ||||
| 0% | |||||
| 12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
| ||||
| IA | |||||
CUSIP No. 76135L101
| Page 3 of 6 Pages | ||||
| 1 | NAMES OF REPORTING PERSONS:
| ||||
| Vik Mittal | |||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):
| ||||
| (a) [ ] | |||||
| (b) [ ] | |||||
| 3 | SEC USE ONLY: | ||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION:
| ||||
| United States | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER:
0 | |||
| 6 | SHARED VOTING POWER:
0 | ||||
| 7 | SOLE DISPOSITIVE POWER:
0 | ||||
| 8 | SHARED DISPOSITIVE POWER:
0 | ||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
| ||||
| 0 | |||||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS):
| ||||
| [ ] | |||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9):
| ||||
| 0% | |||||
| 12 | TYPE OF REPORTING PERSON (SEE INSTRUCTIONS):
| ||||
| IN | |||||
Page 4 of 6 Pages
| Item 1(a) | Name of Issuer:
|
| Revelation Biosciences, Inc. (formerly known as Petra Acquisition Inc.) | |
| Item 1(b) | Address of Issuer’s Principal Executive Offices:
|
| 4660 La Jolla Village Drive, Suite 100, San Diego, CA 92122 | |
| Item 2(a) | Name of Person Filing:
|
| This statement is filed by:
(i) Meteora Capital, LLC, a Delaware limited liability company (“Meteora Capital”) with respect to the common stock (as defined in Item 2(d)) held by certain funds and managed accounts to which Meteora Capital serves as investment manager (collectively, the “Meteora Funds”); and
(ii) Vik Mittal, who serves as the Managing Member of Meteora Capital, with respect to the shares of common stock held by the Meteora Funds.
The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."
The filing of this statement should not be construed as an admission that any of the Reporting Persons is, for the purposes of Section 13 of the Act, the beneficial owner of the shares of Common Stock reported herein. | |
| Item 2(b) | Address of Principal Business Office or, if none, Residence:
|
| The address of the principal business office for each of the Reporting Persons is:
840 Park Drive East, Boca Raton, FL 33444 | |
| Item 2(c) | Citizenship:
|
| Meteora Capital is a Delaware limited liability company. Vik Mittal is a United States citizen. | |
| Item 2(d) | Title of Class of Securities:
|
| Common Stock, par value $0.001 per share | |
| Item 2(e) | CUSIP Number:
|
| 76135L101
On January 10, 2022, the Issuer announced the Common Stock would trade under a new CUSIP 76135L101 as of January 11, 2022. The Issuer’s CUSIP as of December 31, 2021 was 716421102. | |
| Item 3. | If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
|
| (a) □ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b) □ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c) □ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d) □ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e) x An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E);
(f) □ An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F);
(g) x A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G);
(h) □ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) □ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
(j) □ A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J);
(k) □ Group, in accordance with 240.13d-1(b)(1)(ii)(K).
If filing as a non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J), please specify the type of institution: |
Page 5 of 6 Pages
| Item 4. | Ownership |
| The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.
|
| Item 5. | Ownership of Five Percent or Less of a Class.
|
| If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ X ]. | |
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person.
|
| Not applicable | |
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
|
| Not applicable |
| Item 8. | Identification and Classification of Members of the Group.
|
| Not applicable | |
| Item 9. | Notice of Dissolution of Group.
|
| Not applicable | |
| Item 10. | Certifications.
|
| Not applicable |
Exhibits
99.1 Joint Filing Agreement
Page 6 of 6 Pages
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
August 17, 2022
| Meteora Capital, LLC
| |
| By: /s/ Vik Mittal | |
| Name: Vik Mittal | |
| Title: Managing Member | |
| Vik Mittal
| |
| By: /s/ Vik Mittal | |
| Name: Vik Mittal | |
|
|
| 6 |
Exhibit 99.1
JOINT FILING AGREEMENT
Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the “Exchange Act”) the undersigned hereby agree to the joint filing on behalf of each of them of any filing required by such party under Section 13 of the Exchange Act or any rule or regulation thereunder (including any amendment, restatement, supplement, and/or exhibit thereto) with respect to securities of Revelation Biosciences, Inc. (formerly known as Petra Acquisition Inc.), a Delaware corporation, and further agree to the filing, furnishing, and/or incorporation by reference of this Agreement as an exhibit thereto. Each of the undersigned is responsible for the timely filing of such filings and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of the undersigned is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. This Agreement shall remain in full force and effect until revoked by any party hereto in a signed writing provided to each other party hereto, and then only with respect to such revoking party. This Agreement may be executed in any number of counterparts all of which taken together shall constitute one and the same instrument. The undersigned, being duly authorized, have executed this Joint Filing Agreement this 17th day of August, 2022.
| Meteora Capital, LLC
| |
| By: /s/_Vik Mittal | |
| Name: Vik Mittal | |
| Title: Managing Member | |
| Vik Mittal
| |
| By: /s/ Vik Mittal | |
| Name: Vik Mittal |